Researchers Identify Key Determinants Of Relapse In Patients With Chronic Hepatitis B Who Discontinue Nucleos(t)ide Analogue Therapy
April 05, 2021
Infectious Disease Advisor (4/2, Gupta) reported researchers found in a retrospective study that “end-of-therapy hepatitis B surface antigen levels, duration of consolidation therapy, and cirrhosis status are key determinants of relapse in patients with c...